Nath Bio-Genes (Small Cap) Share Target 2024, 2025 To 2039
|
Nath Bio-Genes |
|||
|
Price: ₹188.51 | ||
| 52 Week Low: ₹167.15 52 Week High: ₹264.31 |
|||
| Market Capital: 330.19 Crore (Smallcap) | |||
| Basic Materials -> Agricultural Inputs | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Nath Bio-Genes Share Price Target For 2024
- 1.1.1: Nath Bio-Genes Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Nath Bio-Genes Share Price Target For 2025
- 1.2.1: Nath Bio-Genes Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Nath Bio-Genes Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Nath Bio-Genes Brief Company Overview
- 4: Nath Bio-Genes Financial Performance
- 4.0.1: Is Nath Bio-Genes A Good Buy For Long Term?
To predict the Nath Bio-Genes's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Nath Bio-Genes Share Price Target For 2024
The line chart displays the monthly closing prices of Nath Bio-Genes with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Nath Bio-Genes shares in 2024, see the table below.
Nath Bio-Genes Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 197.46 (+4.74%) | Price Action: 12 Dec 2024 Low |
| 2024 Target 2 | 195.1 (+3.49%) | Price Action: 09 Dec 2024 Low |
| 2024 Target 1 | 192.66 (+2.2%) | Technical Indicator: MA50 |
| Current Price | 188.51 | Nath Bio-Genes's share price as of 23 Dec 2024 |
| Stop Loss 1 | 186.86 (-0.88%) | Price Action: Dec 2024 Low |
| Stop Loss 2 | 184.41 (-2.18%) | Price Action: 30 Oct 2024 Low |
| Stop Loss 3 | 182.3 (-3.3%) | Price Action: 25 Nov 2024 High |
Short-Term Technical Outlook
Current Technical Position: Nath Bio-Genes is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹191.31 serves as the nearest technical reference point.
Historical Returns: 3-month: -11.47% | 6-month: -9.51% | 1-year: -7.46%
Nath Bio-Genes Share Price Target For 2025
The line chart displays the monthly closing prices of Nath Bio-Genes with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Nath Bio-Genes shares in 2025, see the table below.
Nath Bio-Genes Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 258.34 (+37.04%) | Price Action: Chart |
| 2025 Target 2 | 253.52 (+34.47%) | Price Action: Chart |
| 2025 Target 1 | 251.01 (+33.15%) | Fibonacci Extension Level 64.90% |
| Current Price | 188.51 | Nath Bio-Genes's share price as of 23 Dec 2024 |
| Stop Loss 1 | 173.35 (-8.05%) | Price Action: Jul 2022 Low |
| Stop Loss 2 | 171.58 (-8.99%) | Price Action: 21 Nov 2024 Low |
| Stop Loss 3 | 169.11 (-10.3%) | Price Action: Aug 2014 High |
Long-Term Technical Outlook
52-Week Range Analysis: Nath Bio-Genes is currently trading near its 52-week low of ₹167.15, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -7.46% | 3-year: -25.68% | 5-year: -42.81%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Nath Bio-Genes Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹188.51 | ||
| 2024 | ₹205.20 | +8.85% | ₹208.28 |
| 2025 | ₹194.24 | -5.34% | ₹211.02 |
| 2026 | ₹194.65 | +0.21% | ₹205.54 |
| 2027 | ₹196.22 | +0.8% | ₹200.07 |
| 2028 | ₹191.39 | -2.46% | ₹194.60 |
| 2029 | ₹183.94 | -3.89% | ₹190.80 |
| 2030 | ₹173.70 | -5.56% | ₹189.12 |
| 2031 | ₹173.61 | -0.05% | ₹183.65 |
| 2032 | ₹174.55 | +0.54% | ₹178.18 |
| 2033 | ₹169.78 | -2.73% | ₹172.70 |
| 2034 | ₹162.69 | -4.17% | ₹169.13 |
| 2035 | ₹153.15 | -5.86% | ₹167.23 |
| 2036 | ₹152.58 | -0.37% | ₹161.76 |
| 2037 | ₹152.88 | +0.19% | ₹156.28 |
| 2038 | ₹148.16 | -3.08% | ₹150.81 |
| 2039 | ₹140.59 | -5.1% | ₹147.46 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Nath Bio-Genes Brief Company Overview
Nath Bio-Genes (India) Limited: A Leading Seed Pioneer Incorporated in 1979, Nath Bio-Genes (India) Limited is renowned for its high-quality seeds and crop protection supplements. Products: The company offers a comprehensive range of hybrid and GM seeds,...
including fiber and oil seeds, field crop seeds, fruit seeds, and vegetable seeds. Services: Nath Bio-Genes provides crop protection supplements under the WINPro GOLii, WINall, and Win Chi Win brands, as well as forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. Market Presence: The company has a vast network of distributors, dealers, branch offices, warehouses, and processing plants, enabling it to reach customers across India and internationally. Commitment: Nath Bio-Genes is committed to providing farmers with innovative and high-yield seeds and solutions to enhance agricultural productivity.Nath Bio-Genes Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 330.19 Crore | Market valuation of Nath Bio-Genes's shares. |
| Revenue (TTM) | 350.98 Crore | Total revenue generated by Nath Bio-Genes over the past twelve months. |
| Net Income (TTM) | +39.37 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +12.38% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +11.21% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+42.6% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-45.3% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
19.91 | Company's total debt divided by total shareholder equity. |
| Total Debt | 127.49 Crore | Sum of Nath Bio-Genes's current & long-term financial obligations. |
| Total Cash | 2.07 Crore | Total amount of liquid funds available to Nath Bio-Genes. |
| Beta | 1.37 | Beta is greater than 1 indicating that the Nath Bio-Genes's price is more volatile than the market. |
Is Nath Bio-Genes A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
